Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 58Neoplasms 52Colorectal Neoplasms 32Prostatic Neoplasms 29Lung Neoplasms 21Stomach Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 16Uterine Cervical Neoplasms 13Anxiety Disorders 13Colonic Neoplasms 11Brain Neoplasms 11Pancreatic Neoplasms 10Lymphoma, Follicular 9Leukemia, Myeloid, Acute 8Head and Neck Neoplasms 8Barrett Esophagus 8Urinary Bladder Neoplasms 7Rectal Neoplasms 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Disease 7Diabetes Mellitus 7Cholangiocarcinoma 7Sarcoma 6Recurrence 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Pain 6Ovarian Neoplasms 6Motor Activity 6

Interventions

Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Castration-Resistant Prostate Cancer (CRPC) × Clear all
NCT07240857 2026-05-22

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Zhejiang University

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Castration-Resistant Prostate Cancer (CRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡